Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shazad Mushtaq

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
The Journal of Antimicrobial Chemotherapy|April 13, 2013
Activity of biapenem (RPX2003) combined with the boronate β-lactamase inhibitor RPX7009 against carbapenem-resistant EnterobacteriaceaeDavid M Livermore, Shazad Mushtaq
The Journal of Antimicrobial Chemotherapy|January 21, 2010
AmpC induction by ceftarolineShazad Mushtaq, David M Livermore
The Journal of Antimicrobial Chemotherapy|December 10, 2009
Activity of the siderophore monobactam BAL30072 against multiresistant non-fermentersShazad Mushtaq, Marina Warner, David Livermore
The Journal of Antimicrobial Chemotherapy|April 30, 2019
Potentiation of imipenem by relebactam for Pseudomonas aeruginosa from bacteraemia and respiratory infectionsCarolyne Horner, Shazad Mushtaq, David M Livermore, et al.
The Journal of Antimicrobial Chemotherapy|July 3, 2010
Chequerboard titration of cephalosporin CXA-101 (FR264205) and tazobactam versus beta-lactamase-producing EnterobacteriaceaeDavid M Livermore, Shazad Mushtaq, Yigong Ge
Antimicrobial Agents and Chemotherapy|July 27, 2004
Doripenem versus Pseudomonas aeruginosa in vitro: activity against characterized isolates, mutants, and transconjugants and resistance selection potentialShazad Mushtaq, Yigong Ge, David M Livermore
The Journal of Antimicrobial Chemotherapy|May 23, 2013
Activity of MK-7655 combined with imipenem against Enterobacteriaceae and Pseudomonas aeruginosaDavid M Livermore, Marina Warner, Shazad Mushtaq
The Journal of Antimicrobial Chemotherapy|July 31, 2020
Activity of ceftaroline versus ceftobiprole against staphylococci and pneumococci in the UK and Ireland: analysis of BSAC surveillance dataCarolyne Horner, Shazad Mushtaq, David M Livermore, et al.
International Journal of Antimicrobial Agents|December 24, 2013
Methodological agreement on the in vitro activity of ceftaroline against cefotaxime-susceptible and -resistant pneumococciDavid M Livermore, Marina Warner, Shazad Mushtaq
The Journal of Antimicrobial Chemotherapy|September 18, 2010
Activity of BAL30376 (monobactam BAL19764 + BAL29880 + clavulanate) versus Gram-negative bacteria with characterized resistance mechanismsDavid M Livermore, Shazad Mushtaq, Marina Warner
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
The Journal of Antimicrobial Chemotherapy|April 13, 2013
Activity of biapenem (RPX2003) combined with the boronate β-lactamase inhibitor RPX7009 against carbapenem-resistant EnterobacteriaceaeDavid M Livermore, Shazad Mushtaq
The Journal of Antimicrobial Chemotherapy|January 21, 2010
AmpC induction by ceftarolineShazad Mushtaq, David M Livermore
The Journal of Antimicrobial Chemotherapy|December 10, 2009
Activity of the siderophore monobactam BAL30072 against multiresistant non-fermentersShazad Mushtaq, Marina Warner, David Livermore
The Journal of Antimicrobial Chemotherapy|April 30, 2019
Potentiation of imipenem by relebactam for Pseudomonas aeruginosa from bacteraemia and respiratory infectionsCarolyne Horner, Shazad Mushtaq, David M Livermore, et al.
The Journal of Antimicrobial Chemotherapy|July 3, 2010
Chequerboard titration of cephalosporin CXA-101 (FR264205) and tazobactam versus beta-lactamase-producing EnterobacteriaceaeDavid M Livermore, Shazad Mushtaq, Yigong Ge
Antimicrobial Agents and Chemotherapy|July 27, 2004
Doripenem versus Pseudomonas aeruginosa in vitro: activity against characterized isolates, mutants, and transconjugants and resistance selection potentialShazad Mushtaq, Yigong Ge, David M Livermore
The Journal of Antimicrobial Chemotherapy|May 23, 2013
Activity of MK-7655 combined with imipenem against Enterobacteriaceae and Pseudomonas aeruginosaDavid M Livermore, Marina Warner, Shazad Mushtaq
The Journal of Antimicrobial Chemotherapy|July 31, 2020
Activity of ceftaroline versus ceftobiprole against staphylococci and pneumococci in the UK and Ireland: analysis of BSAC surveillance dataCarolyne Horner, Shazad Mushtaq, David M Livermore, et al.
International Journal of Antimicrobial Agents|December 24, 2013
Methodological agreement on the in vitro activity of ceftaroline against cefotaxime-susceptible and -resistant pneumococciDavid M Livermore, Marina Warner, Shazad Mushtaq
The Journal of Antimicrobial Chemotherapy|September 18, 2010
Activity of BAL30376 (monobactam BAL19764 + BAL29880 + clavulanate) versus Gram-negative bacteria with characterized resistance mechanismsDavid M Livermore, Shazad Mushtaq, Marina Warner
Pageof 8